StonvexLoading…
StonvexStonvexStonvexCore line items from REKR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $48.45M | $46.03M | $34.93M | $19.92M |
Operating Income | $-28.89M | $-54.32M | $-42.12M | $-85.78M |
Net Income | $-31.46M | $-61.41M | $-45.69M | $-83.11M |
EPS (Diluted) | $-0.26 | $-0.71 | $-0.72 | $-1.67 |
Total Assets | $85.39M | $82.47M | $92.15M | $83.84M |
Total Liabilities | $42.52M | $48.33M | $58.78M | $34.50M |
Cash & Equivalents | $16.57M | $5.01M | $15.38M | $1.92M |
Free Cash Flow OCF − CapEx | $-22.90M | $-34.15M | $-34.02M | $-42.60M |
Shares Outstanding | 136.48M | 104.54M | 69.18M | 54.41M |